The Drug-Eluting Bioabsorbable Stents Market is expected to grow from USD 393.31 million in 2019 and to reach USD 579.87 million by 2027, growing at a CAGR of 9% during the forecast period 2021-2027.

The drug-eluting bioabsorbable stent is a device developed in the form of a tube. It is located inside a coronary artery or diseased periphery. The drug is slowly released into the arteries to block cell proliferation. Drug-eluting bioabsorbable stents are considered superior to bare metal stents due to the fact that they reduce coronary restenosis and vascular restenosis. It reduces the chances of a heart attack by minimizing the occurrence of plaque build-up and increasing blood flow to the heart. The whole procedure is minimally invasive compared to coronary artery bypass grafting.

(Get 15% Discount on Buying this Report)

A full report of Global Drug-Eluting Bioabsorbable Stents Market is available at:

Market Segments

By Product

  • Serolimus
  • Paclitaxel
  • Sirolimus
  • Everolimus
  • Zotarolimus
  • Others

By Material Type

  • Polymer
  • Metallic

By Application

  • Coronary Artery Diseases
  • Peripheral Artery Diseases

Key Players

Some of the other notable industry vendors are MicroPort Scientific Corporation, Alvimedica, Biotronik, Elixir Medical Corporation, and Innovative Health Technologies.

Scope of the Report

The research study analyzes the global Drug-Eluting Bioabsorbable Stents industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Drug-Eluting Bioabsorbable Stents Market Report

1. What was the Drug-Eluting Bioabsorbable Stents Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Drug-Eluting Bioabsorbable Stents Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Drug-Eluting Bioabsorbable Stents Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

  • Proliferation and maturation of trade in the global Drug-Eluting Bioabsorbable Stents market.
  • The market share of the global Drug-Eluting Bioabsorbable Stents market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
  • Current and future market trends that are influencing the growth opportunities and growth rate of the global Drug-Eluting Bioabsorbable Stents market.
  • Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Drug-Eluting Bioabsorbable Stents market.

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404